共 183 条
[1]
Cumberbatch MGK(2018)Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018 Eur Urol 74 784-795
[2]
Jubber I(2022)Cancer statistics, 2022 CA Cancer J Clin 72 7-33
[3]
Black PC(2019)European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 Update Eur Urol 76 639-657
[4]
Esperto F(2016)Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline J Urol 196 1021-1029
[5]
Figueroa JD(1999)Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder J Urol 162 1946-1950
[6]
Kamat AM(2012)Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guerin Eur Urol 62 118-125
[7]
Siegel RL(2011)Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic review Eur Urol 60 493-500
[8]
Miller KD(2009)Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with Bacillus Calmette-Guerin: the CUETO scoring model J Urol 182 2195-2203
[9]
Fuchs HE(2006)Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol. 49 466-5
[10]
Jemal A(2001)A systematic review of intravesical bacillus Calmette-Guerin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer BJU Int 88 209-216